As it gains a foothold in European markets, Molecular Health has started distributing the latest…
Patients & physicians
Give the diagnosis a better prognosis
Every physician wants to be confident they are giving patients the best possible care. Molecular Health helps physicians make customized therapeutic decisions based on molecular genetics allowing to uncover which therapies are most likely to work – and which are not.
Pharma & Biotech
Improve the prediction of drug
outcomes and pick the winners
With increasing health issues all over the world and the need for faster and cheaper drug development, it is necessary to start leveraging the vast data ocean of life sciences. Bringing together AI with predictive analytics and real-world data (RWD) is where it might be game changing: Predicting the success of clinical trials can redirect the focus of pharma and biotech companies onto compounds with the most potential, bringing drugs faster to the patients who need them.
The widespread disease of cancer has many manifestations and degrees of severity. Promising progress has…
Heidelberg – September 19, 2019 – Molecular Health, a leading company in the field of data science…
Integrating insight has never been easier
Over the last decade, Dataome has grown to become one of the largest globally available resources of clinico-molecular data and knowledge. From millions of patient lives to hundreds of billions of molecular data points, it provides a single-point of access to the worlds biomedical knowledge through our decision support applications.
Molecular Health Predict (MH Predict) is an application to predict clinical trials probabilities of success. It enables the improvement of clinical trial success and reduces clinical trial failure while optimizing resource allocation for the biopharma industry and investors and enhancing the overall efficiency of drug development.
Molecular Health Guide Mendel (MH Mendel) supports human geneticists to identify clinically significant genetic variants and create a diagnostic report for individual patients. MH Mendel is part of the Molecular Health Guide (MH Guide) solution which is an IVD registered in the EU.
Molecular Health Guide (MH Guide) identifies safe and effective therapies for patients by analyzing the molecular profile. It matches detected mutations to the world’s knowledge in the field of oncology and hereditary diseases and helps medical experts to create a patient-specific clinical report. MH Guide is an IVD registered in the EU.
Molecular Health Guide BRCA (MH BRCA) supports medical professionals in identifying and reporting clinically significant germline variants associated with hereditary breast and ovarian cancer (HBOC) syndrome from NGS-based assessment of BRCA1 and BRCA2 and other HBOC related genes. MH BRCA is part of the Molecular Health Guide (MH Guide) solution which is an IVD registered in the EU.
You’re in good company
Molecular Health’s growing number of customers and partnerships include some of the best hospitals, laboratories, universities, and genetic facilities in the world.
Let’s talk about how our technology can work for you
To find out more, you can call our customer care team or send us an e-mail. We would be delighted to provide you with more information or answer your questions.